Heritage Is First To Settle DOJ Generic Drug Price Fixing Probe; Will Others Follow?
Executive Summary
Heritage agrees to pay $7.1m to resolve civil allegations and a $225,000 criminal penalty. DOJ defers prosecution of one felony charge.
You may also be interested in...
Rising's Generic Price Fixing Settlement Follows Bankruptcy, Cooperation
Rising Pharmaceuticals agrees to pay $3.1m, admits to conspiring to fix prices for hypertension drug, and enters into deferred prosecution agreement. Pfizer asks court to be removed from complaint by state AGs.
Rising's Generic Price Fixing Settlement Follows Bankruptcy, Cooperation With DOJ
Rising Pharmaceuticals agrees to pay $3.1m, admits to conspiring to fix prices for hypertension drug, and enters into deferred prosecution agreement. Pfizer asks court to be removed from complaint by state AGs.
US Price-Fixing Litigation Presses On With 'Overarching Conspiracy' Claims Intact
Judge allows plaintiffs to argue attendance at trade association meetings and job-hopping show scheme to fix drug prices; confidentiality of attorney communication is in dispute.